In the fast-paced world of healthcare, accurate and efficient diagnostic tools are crucial for providing timely medical interventions. Tianlong, a renowned leader in the field of in vitro diagnostic devices, has been at the forefront of innovative solutions for over two decades. With a strong focus on product excellence and a dedication to advancing the healthcare industry, Tianlong has gained recognition for its cutting-edge technologies and comprehensive business coverage.
Innovative Product Portfolio: The Panall 8000 All-in-one Molecular Diagnosis System
At the heart of Tianlong’s product portfolio lies the Panall 8000 All-in-one Molecular Diagnosis System. This revolutionary device integrates various crucial diagnostic processes into one seamless platform, optimizing workflow and reducing processing time. The Panall 8000 boasts state-of-the-art features, including nucleic acid extraction, PCR thermal cycling, and real-time PCR detection, all designed to meet the diverse needs of modern healthcare facilities. Featuring a sample-in-result-out configuration, the enclosed system reduces the potential for contamination. The user-friendly 12.1-inch touchscreen negates the requirement for extra equipment or result analysis. Enabling simultaneous testing of 8 samples and providing various fluorescence detection channels, the Panall 8000 ensures reliable outcomes. Compact dimensions measuring 750mm x 350mm x 580mm and a weight of 75Kg enhance its versatility within laboratory environments, underscoring its inventive and pragmatic nature.
Pioneering Technology: Advancing In Vitro Diagnostics
Tianlong’s commitment to innovation drives its continuous pursuit of pioneering technology. With over 80 autonomous intellectual property rights, Tianlong’s R&D team works tirelessly to develop cutting-edge solutions that push the boundaries of in vitro diagnostics. The Panall 8000, with its powerful software analysis capabilities and efficient temperature control system, exemplifies Tianlong’s dedication to providing accurate and reliable results to healthcare professionals.
Expanding Business Coverage: A Global Impact
Tianlong’s reach extends far beyond its headquarters in China. With products that have obtained more than 70 China NMPA approvals and over 120 international approvals and certifications, Tianlong has established a strong presence in more than 100 countries and regions worldwide. Its in vitro diagnostic devices are now widely applied in clinical diagnostics, epidemic prevention and control, food safety, and scientific research, making a significant impact on global healthcare.
Conclusion: Transforming Healthcare with Tianlong’s Vision
Tianlong’s unwavering commitment to excellence, innovation, and comprehensive business coverage has positioned it as a global leader in in vitro diagnostics. With its flagship product, the Panall 8000 All-in-one Molecular Diagnosis System, Tianlong continues to advance the field of healthcare diagnostics, empowering medical professionals with cutting-edge tools for accurate and efficient diagnoses. As the healthcare industry evolves, Tianlong’s vision remains focused on creating first-class molecular diagnostic products for human well-being, solidifying its role as a trailblazer in the field of in vitro diagnostic devices.
